Regarding the titers, although a trend to associate the presence of anti-CFECHAP-2 median titers with ILD (p = 0.064), the differences were only significant for CFECHAP-1 and the chimeric containing fibrin and filaggrin peptides (CFFCHAPs) that we previously reported [13]. This evidence concerns the gene FLG and interstitial lung disease.